CGT

1,163개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,163 programs
CGTLimited DatastaleUnion Hospital, Tongji Medical …Phase 1

CD19/BCMA CAR-T cell therapy (CD19/BCMA CAR-T cell therapy)

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleWest China HospitalPhase 1

CD19/BCMA in vivo CAR-T (CD19/BCMA in vivo CAR-T)

Autoimmune Diseases · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleThe First Affiliated Hospital o…Phase 1

CD19/BCMA-Targeted Universal Chimeric Antigen Receptor T Cells (UCAR-T, CD19/BCMA-Targeted Universal Chimeric Antigen Receptor T Cells, CD19/BCMA-Targeted Universal Chimeric Antigen Receptor T Cells (UCAR-T) infusing)

Refractory Idiopathic Membranous Nephropathy · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleZhejiang UniversityPhase 1

CD19/BCMA-targeted CAR-T cells (CD19/BCMA-targeted CAR-T cells)

Multiple Myeloma in Relapse; Multiple Myeloma, Refractory · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleHenan Hualong Biotechnology Com…Phase 1

CD19/CD20 bispecific CAR-T cells (CD19/CD20 bispecific CAR-T cells)

B-Cell Lymphoma Stage I; Refractory · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastalePeking UniversityPhase 1

CD19/CD20-directed Chimeric Antigen Receptor T Cells (CD19/CD20-directed Chimeric Antigen Receptor T Cells)

B Cell Non-Hodgkin's Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleShanghai Cell Therapy Group Co.…Phase 1

CD19/CD20/BCMA CAR T cells (CD19/CD20/BCMA CAR T cells)

Non-Hodgkin Lymphoma, B-cell · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Cell Therapy Group Co.…Phase 1

CD19/CD20/BCMA CAR-T (CD19/CD20/BCMA CAR-T)

Relapsed; Refractory · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 2

CD19/CD22-CAR-transduced T cells (CD19/CD22-CAR-transduced T cells)

B-NHL; B-Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Cell Therapy Group Co.…Phase 1

BZE2204 (CD19/CD22/BCMA CAR-T cells, CD19/CD22/BCMA CAR-T cells(BZE2204))

Idiopathic Inflammatory Myopathies(IIM); Immune Thrombocytopenia(ITP) · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleUniversity College, LondonPhase 1

CD19CAR T-cells (CD19CAR T-cells)

Primary CNS Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleUniversity of Colorado, DenverPhase 2

CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells)

B-cell Acute Lymphoblastic Leukemia; B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleUniversity College, LondonPhase 1

CD19CAT-41BBZ CAR T-cells (CD19CAT-41BBZ CAR T-cells)

Leukemia, Lymphoblastic, Acute, Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleInstitute of Hematology & Blood…Phase 2

CD19X CAR-T (CD19X CAR-T)

Large B-Cell Lymphoma (LBCL) · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleUniversity of Colorado, DenverPhase 1

CD19x22 CAR T (CD19x22 CAR T)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Longyao Biotechnology …Phase 1

CD20 CAR-T (CD20 CAR-T)

Relapsed and Refractory B Cell Lymphoma; Non-Hodgkin Lymphoma · CD20

#CD20#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

CD20-CD19 cCAR T cells (CD20-CD19 cCAR T cells)

B Cell Lymphoma; B Cell Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleShanghai AbelZeta Ltd.Phase 1

CD20-directed CAR-T cells with CliniMACS Prodigy® system (CD20-directed CAR-T cells with CliniMACS Prodigy® system)

B Cell Lymphoma · CD20

#CD20#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleHe HuangPhase 1

CD20/CD22 dual Targeted CAR T-cells (CD20/CD22 dual Targeted CAR T-cells)

Relapsed and Refractory; Lymphoid Hematological Malignancies · CD20

#CD20#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing Friendship HospitalPhase 1

CD207 CAR-T cells (CD207 CAR-T cells)

Langerhans Cell Histiocytosis · CD20

#CD20#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active

35 / 59 pages

← PreviousNext →